Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool
Heloise Bourien, Véronique Quillien, Florence Godey, Christophe Perrin, Fanny Le Du, Sophie Guillermet, Jerome Blanchot, Vincent Lavoué, Boris Campillo-Gimenez, Angelique Brunot, Laurence Crouzet, Thibault de La Motte Rouge, Véronique Diéras, Claudia Lefeuvre-Plesse
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.